Selective estrogen receptor modulators (SERMs) for the brain: Current status and remaining challenges for developing NeuroSERMs
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 49 (3) , 472-493
- https://doi.org/10.1016/j.brainresrev.2005.01.009
Abstract
No abstract availableKeywords
This publication has 176 references indexed in Scilit:
- Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's diseaseExperimental Neurology, 2004
- Selective estrogen receptor modulators (SERM) for the brain: Recent advances and remaining challenges for developing a NeuroSERM?Drug Development Research, 2002
- Expression of estrogen receptor-beta protein and mRNA in the cerebellum of the ratNeuroscience Letters, 2000
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trialEuropean Journal Of Cancer, 1992
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorPublished by Elsevier ,1975
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971